#HVO hVIVO PLC – Issue of Equity and Total Voting Rights February 23, 2026 – Posted in: hVIVO (HVO)

London, UK – 23 February 2026, hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces the issue of 1,386,991 new Ordinary Shares of £0.001 each in the Company (“First Consideration Shares”) to three managers of Cryo-Store Limited (“Cryostore”). This issuance comprises the first tranche (50%) of the equity consideration payable pursuant to the acquisition of Cryostore announced on 27 February 2025 (the “Acquisition”). …

#POLB Poolbeg Pharma PLC – Notification of Major Holdings June 26, 2025 – Posted in: Poolbeg Pharma (POLB)

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Poolbeg Pharma plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

#TSP TruSpine Technologies PLC – Holdings in Company May 29, 2025 – Posted in: TruSpine Plc (TSP)

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: TruSpine Technologies PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

#POLB Poolbeg Pharma PLC – Holding(s) in Company January 9, 2025 – Posted in: Uncategorized

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Poolbeg Pharma PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification…

#VELA investee co. #KING Igraine PLC – Maiden Exercise of Investment Rights Over GEM Energia December 13, 2024 – Posted in: Vela Technologies Plc (VELA)

Igraine plc (AQSE: KING), an investing company focused on the development of battery energy storage and life sciences sectors, is pleased to update its shareholders regarding its exercise of investment rights with GEM Energia. As announced on 21 October 2024 and further to the announcement of 2 December 2024, Igraine secured the exclusive investment rights over GEM Energia Limited and its Special Purpose Vehicles, including a right of first refusal on all current and future…

#VELA investee co. #KING Igraine PLC – Grant of Investment Rights Over GEM, Conditional Loan Facility with Vela Technologies, Appointment of Executive Director and Proposed Issuance of Equity October 21, 2024 – Posted in: Vela Technologies Plc (VELA)

The Board of Igraine (AQSE: KING), an investment issuer focused on opportunities in breakthrough technologies and life sciences, is pleased to announce several significant developments, including the grant of investment rights over GEM Energia Limited (“GEM”), the establishment of a Convertible Loan Facility with Vela Technologies plc (“Vela”) and the appointment of Mr David Levis as an Executive Director. Highlights: Secured exclusive investment rights in relation to GEM and its subsidiaries, including a right of…

#VELA Technologies PLC – Holding(s) in Company July 31, 2024 – Posted in: Vela Technologies Plc (VELA)

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Vela Technologies Plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

#TSP TruSpine Technologies PLC – Convertible Loan Note Conversion & Issue of Equity June 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 26 March 2024, the Company has elected to convert the Lender CLN Subscription of £200,000 into 13,333,333 new ordinary shares at a price of 1.5 pence per share (“CLN Shares”) pursuant to the terms of the CLN Instrument. Admission Application has been made for the CLN Shares to be admitted to trading…

#TSP TruSpine Technologies PLC – Major Shareholding May 29, 2024 – Posted in: TruSpine Plc (TSP)

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: TruSpine Technologies PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

#VELA investee co. #TSP TruSpine Technologies PLC – Update re Loan May 9, 2023 – Posted in: TruSpine Plc (TSP), Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces an update to the announcement released by the Company on 28 February 2023 in relation to the Loan Agreement entered into by the Company. The announcement of 28 February 2023 omitted to disclose a fixed and floating charge over the Company’s intellectual property to the lender as security for the proceeds of which were received on 27 February 2023.…